Inspire Medical Systems INSP Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 85.8%+0.4pp | 85.4%+0.5pp | 84.9%+0.4pp | 84.5%-0.2pp | 84.7%0.0pp | |
| Operating margin | 5.6%0.0pp | 5.6%+1.4pp | 4.2%— | —— | —— | |
| Net margin | 14.3%-1.6pp | 15.9%+10.9pp | 5%— | —— | —— | |
| EBITDA margin | 7.4%+0.2pp | 7.1%+1.5pp | 5.6%— | —— | —— | |
| Free cash flow margin | 10.6%+2.0pp | 8.6%-2.6pp | 11.2%+1.3pp | 9.9%+0.5pp | 9.4%-2.0pp | |
| Returns | ||||||
| Return on equity | 18.4%-1.4pp | 19.8%+13.2pp | 6.5%— | —— | —— | |
| Return on assets | 16%-1.0pp | 17%+11.4pp | 5.6%— | —— | —— | |
| Return on invested capital | 7.7%-0.3pp | 8%+2.5pp | 5.4%— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 1.1×+0.1× | 1.1×0.0× | 1.1×0.0× | 1.1×-0.1× | 1.2×+0.1× | |
| Inventory turnover | 1×-0.2× | 1.2×-0.1× | 1.3×-0.2× | 1.5×-0.3× | 1.7×-0.4× | |
| Liquidity | ||||||
| Current ratio | 6.3×+0.3× | 6.1×+0.8× | 5.3×-0.8× | 6.1×-2.9× | 9×+1.9× | |
| Quick ratio | 4.5×-0.1× | 4.6×+0.6× | 4×-0.8× | 4.8×-2.6× | 7.4×+1.2× | |
| Cash ratio | 1.1×0.0× | 1.1×+0.1× | 1×-0.1× | 1.1×+0.3× | 0.8×-0.8× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Net debt / EBITDA | -1×+0.1× | -1.1×+0.5× | -1.6×— | —— | —— | |
| Per Share | ||||||
| Book value per share | $27.61+5.2% | $26.25+16.6% | $22.52-2.0% | $22.97+9.5% | $20.97-7.1% | |
| Valuation | ||||||
| Market capitalization | $1.25B-67.6% | $2.68B+22.1% | $2.19B-43.9% | $3.91B-17.5% | $4.74B-14.7% | |
| Enterprise value | $1.18B-69.2% | $2.61B+23.3% | $2.11B-44.9% | $3.84B-18.7% | $4.72B-13.2% | |
| Price / earnings | 9.6×-48.5× | 18.4×-30.8× | 49.3×— | —— | —— | |
| Price / sales | 1.4×-3.2× | 2.9×+0.5× | 2.5×-2.1× | 4.5×-1.1× | 5.6×-1.3× | |
| Price / book | 1.6×-4.5× | 3.4×+0.1× | 3.3×-2.5× | 5.8×-1.7× | 7.5×-0.6× | |
| EV / EBITDA | 17.6×-48.0× | 40.2×-2.7× | 42.8×— | —— | —— | |
| EV / sales | 1.3×-3.3× | 2.9×+0.5× | 2.4×-2.1× | 4.5×-1.2× | 5.6×-1.2× | |
| Free cash flow yield | 7.7%+5.7pp | 2.9%-1.6pp | 4.5%+2.3pp | 2.2%+0.5pp | 1.7%0.0pp | |
| Earnings yield | 10.5%+8.8pp | 5.4%+3.4pp | 2%— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Inspire Medical Systems's profit margins?
- Inspire Medical Systems (INSP) runs a 85.8% gross margin and a 5.6% operating margin, with a 14.3% net margin.
- Where do Inspire Medical Systems's ratios come from?
- Every ratio is computed from Inspire Medical Systems's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
